Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface [Phase 1]
A Phase 1 study evaluating different doses of BI-765049 alone and in combination with Ezabenlimab in patients with advanced solid tumors exp…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 2]
A Phase 2 study of PRT3789 in combination with pembrolizumab for SMARCA4-mutant advanced or metastatic solid tumors was terminated. The stud…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation [Phase 1]
A Phase 1 study of PRT7732, an oral SMARCA2 degrader, in patients with SMARCA4-mutant advanced or metastatic solid tumors has been terminate…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial evaluating Local Ablative Therapy for people with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating tiragolumab in combination with atezolizumab versus placebo with atezolizumab in previously untreated PD-L1-selecte…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 study comparing sotorasib with durvalumab in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study of pembrolizumab (MK-3475) in combination with gemcitabine for non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade [Phase 1, Phase 2]
Phase 1/2 trial evaluating interleukin-2 with radiotherapy and pembrolizumab in patients refractory to checkpoint blockade; results have bee…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients
A clinical trial update indicates that a study evaluating pembrolizumab drug concentration monitoring in patients with non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: PembRolIzuMab and Stereotactic Body Radiotherapy In Metastatic Non-small-cell lunG Cancer Patients [Phase 1]
A Phase 1 trial evaluating pembrolizumab with stereotactic body radiotherapy in metastatic non-small cell lung cancer was terminated, and th…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial update for HER3-DXd in locally advanced or metastatic solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib [Phase 2]
A Phase 2 clinical trial is evaluating trilaciclib to prevent chemotherapy-induced bone marrow suppression in advanced non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Impact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable Mutations
A clinical trial update evaluating whether reducing chemotherapy doses affects survival in older patients with non-small cell lung cancer la…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm [Phase 2]
Clinical trial update indicating the Phase 2 study of adjuvant osimertinib in non-small cell lung cancer with uncommon EGFR mutations is cur…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment. [Phase 1]
A Phase 1 trial evaluates BI 754111 alone and in combination with BI 754091 in patients with advanced cancer, testing multiple doses to iden…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Large Granular Lymphocytes in mNSCLC Treated With Nivolumab
A clinical trial update indicates recruitment is ongoing for a study of large granular lymphocytes in metastatic non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations [Phase 2]
This clinical trial update reports a Phase 2 study of LY2875358 in participants with non-small cell lung cancer harboring activating EGFR mu…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC [Phase 2]
A Phase 2 clinical trial update evaluating tiragolumab in combination with atezolizumab and bevacizumab for previously treated advanced non-…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: First in Human Study of SIM0610 in Solid Tumors [Phase 1]
A first-in-human Phase 1 study of SIM0610 in solid tumors is underway, evaluating safety and dosing across multiple indications including No…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Zorifertinib With Osimertinib for NSCLC With Meningeal Progression [Phase 1]
The document reports a Phase 1 clinical trial evaluating Zorifertinib in combination with Osimertinib for patients with advanced non-small c…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: SLV-154 Treatment of Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for SLV-154 evaluating treatment of metastatic solid tumors. The study is currently recruiting across multiple…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) [Phase 3]
A Phase 3 neoadjuvant trial (IMpower030) evaluating atezolizumab plus chemotherapy versus chemotherapy alone in resectable non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study of TAK-500 with or without pembrolizumab in adults with select locally advanced or metastatic solid tumors; the trial was …
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of adding Durvalumab with consolidative hypofractionated radiotherapy for residual n…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases [Phase 2]
Phase 2 study of tiragolumab plus atezolizumab in non-squamous non-small cell lung cancer with untreated brain metastases has been terminate…